Employer profile
Quoin Pharmaceuticals
3 certified H-1B filings across 3 fiscal years.
FY2025 filings
1
FY2025 median
$302k
Top role
Director
2 filings
Top state
NY
3 filings
Quoin Pharmaceuticals has filed 3 certified H-1B Labor Condition Applications over FY2021–FY2025. In FY2025, its median certified base salary was $302k ($302k–$302k interquartile range). The most-filed role is Director (2 filings).
Year-over-year
How Quoin Pharmaceuticals hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2025 | 1 | $302k | 0 |
| FY2023 | 1 | $302k | 0 |
| FY2021 | 1 | $302k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Director | 2 | $302k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| NY | 3 | $302k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl IV
3100%
Frequently asked questions
- Does Quoin Pharmaceuticals sponsor H-1B visas?
- Yes. Quoin Pharmaceuticals has filed 3 certified H-1B Labor Condition Applications (LCAs) over FY2021–FY2025. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Quoin Pharmaceuticals?
- In FY2025, the median certified H-1B base salary at Quoin Pharmaceuticals was $302k, with a 25th–75th percentile range of $302k–$302k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Quoin Pharmaceuticals hire H-1B workers for?
- Quoin Pharmaceuticals's most-filed H-1B role is Director (2 filings). Its top worksite state is NY.
- How many H-1B filings did Quoin Pharmaceuticals submit in FY2025?
- Quoin Pharmaceuticals had 1 certified H-1B LCA filings in FY2025 — a level reading from the prior fiscal year.